BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28261852)

  • 1. Acute leukaemia with a pure erythroid phenotype: under-recognized morphological and cytogenetic signatures associated universally with primary refractory disease and a dismal clinical outcome.
    Park DC; Ozkaya N; Lovitch SB
    Histopathology; 2017 Aug; 71(2):316-321. PubMed ID: 28261852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification.
    Liu W; Hasserjian RP; Hu Y; Zhang L; Miranda RN; Medeiros LJ; Wang SA
    Mod Pathol; 2011 Mar; 24(3):375-83. PubMed ID: 21102413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous disease.
    Kasyan A; Medeiros LJ; Zuo Z; Santos FP; Ravandi-Kashani F; Miranda R; Vadhan-Raj S; Koeppen H; Bueso-Ramos CE
    Mod Pathol; 2010 Aug; 23(8):1113-26. PubMed ID: 20473273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How unique is pure erythroid leukaemia? A retrospective analysis of seven cases and review of the literature.
    Wong E; Ling V; Westerman D; Morgan S; Juneja S
    J Clin Pathol; 2015 Apr; 68(4):301-5. PubMed ID: 25609576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pure Erythroid Leukemia and Erythroblastic Sarcoma Evolving From Chronic Myeloid Neoplasms.
    Li H; Hasserjian RP; Kroft SH; Harrington AM; Wheaton SE; Pildain A; Ewalt MD; Gratzinger D; Hosking P; Olteanu H
    Am J Clin Pathol; 2016 Apr; 145(4):538-51. PubMed ID: 27124944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases.
    Reichard KK; Tefferi A; Abdelmagid M; Orazi A; Alexandres C; Haack J; Greipp PT
    Blood Cancer J; 2022 Nov; 12(11):147. PubMed ID: 36323674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of 97 previously diagnosed de novo adult acute erythroid leukemia patients following the 2016 revision to World Health Organization classification.
    Qiu S; Jiang E; Wei H; Lin D; Zhang G; Wei S; Zhou C; Liu K; Wang Y; Liu B; Liu Y; Gong B; Gong X; Feng S; Mi Y; Han M; Wang J
    BMC Cancer; 2017 Aug; 17(1):534. PubMed ID: 28793875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The uniqueness of morphological features of pure erythroid leukemia in myeloid neoplasm with erythroid predominance: A reassessment using criteria revised in the 2016 World Health Organization classification.
    Ko PS; Liu YC; Yeh CM; Gau JP; Yu YB; Hsiao LT; Tzeng CH; Chen PM; Chiou TJ; Liu CJ; Liu JH
    PLoS One; 2017; 12(2):e0172029. PubMed ID: 28196090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloid leukaemia (M6B: pure acute erythroid leukaemia) in a Thoroughbred foal.
    Forbes G; Feary DJ; Savage CJ; Nath L; Church S; Lording P
    Aust Vet J; 2011 Jul; 89(7):269-72. PubMed ID: 21696377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythroleukemia: a need for a new definition.
    Park S; Picard F; Dreyfus F
    Leukemia; 2002 Aug; 16(8):1399-401. PubMed ID: 12145675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria.
    Margolskee E; Mikita G; Rea B; Bagg A; Zuo Z; Sun Y; Goswami M; Wang SA; Oak J; Arber DA; Allen MB; George TI; Rogers HJ; Hsi E; Hasserjian RP; Orazi A
    Mod Pathol; 2018 Jun; 31(6):873-880. PubMed ID: 29403082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphologic, immunologic and cytogenetic studies in erythroleukaemia: evidence for multilineage involvement and identification of two distinct cytogenetic-clinicopathological types.
    Cuneo A; Van Orshoven A; Michaux JL; Boogaerts M; Louwagie A; Doyen C; Dal Cin P; Fagioli F; Castoldi G; Van den Berghe H
    Br J Haematol; 1990 Jul; 75(3):346-54. PubMed ID: 2386768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology Group.
    Chisholm KM; Heerema-McKenney AE; Choi JK; Smith J; Ries RE; Hirsch BA; Raimondi SC; Alonzo TA; Wang YC; Aplenc R; Sung L; Gamis AS; Meshinchi S; Kahwash SB
    Blood Adv; 2020 Dec; 4(23):6000-6008. PubMed ID: 33284945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo erythroleukemia chromosome features include multiple rearrangements, with special involvement of chromosomes 11 and 19.
    Cigudosa JC; Odero MD; Calasanz MJ; Solé F; Salido M; Arranz E; Martínez-Ramirez A; Urioste M; Alvarez S; Cervera JV; MacGrogan D; Sanz MA; Nimer SD; Benitez J
    Genes Chromosomes Cancer; 2003 Apr; 36(4):406-12. PubMed ID: 12619165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity.
    Reinig EF; Greipp PT; Chiu A; Howard MT; Reichard KK
    Mod Pathol; 2018 May; 31(5):705-717. PubMed ID: 29327715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of clinical, haematological and cytogenetic profile of patients with acute erythroid leukaemia.
    Linu JA; Udupa MN; Madhumathi DS; Lakshmaiah KC; Babu KG; Lokanatha D; Babu MS; Lokesh KN; Rajeev LK; Rudresha AH
    Ecancermedicalscience; 2017; 11():712. PubMed ID: 28144286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification.
    Hasserjian RP; Zuo Z; Garcia C; Tang G; Kasyan A; Luthra R; Abruzzo LV; Kantarjian HM; Medeiros LJ; Wang SA
    Blood; 2010 Mar; 115(10):1985-92. PubMed ID: 20040759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential characteristics of TP53 alterations in pure erythroid leukemia arising after exposure to cytotoxic therapy.
    Tashakori M; Wang W; Kadia TM; Daver NG; Montalban-Bravo G; Loghavi S; Wang SA; Medeiros LJ; Ravandi F; Khoury JD
    Leuk Res; 2022 Jul; 118():106860. PubMed ID: 35636055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythroleukemia: a comparison between the previous FAB approach and the WHO classification.
    Park S; Picard F; Azgui Z; Viguie F; Merlat A; Guesnu M; Leblond V; Dreyfus F
    Leuk Res; 2002 May; 26(5):423-9. PubMed ID: 11916513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.